As of 2026-04-05, the Relative Valuation of Impel Neuropharma Inc (IMPL) is (475.73) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.24 USD, the upside of Impel Neuropharma Inc based on Relative Valuation is -197416.1%.
The range of the Relative Valuation is (466.95) - (495.59) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.2x - 22.7x | 20.4x |
| Forward P/E multiples | 19.2x - 21.5x | 20.8x |
| Fair Price | (466.95) - (495.59) | (475.73) |
| Upside | -193776.3% - -205653.6% | -197416.1% |
| Date | P/E |